Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Get Alerts

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK · BSE: 532296 · Pharmaceuticals & Biotechnology · 39 announcements

Glenmark Pharmaceuticals Ltd news stories on ALFA NewsRead the news →
Share price
₹2,293.50
Market cap
₹64,728 Cr
Revenue (annual)
₹16,983 Cr
Net profit (annual)
₹1,362 Cr
P/E (TTM)
36.0×Sector 47.4×
Promoter holding
46.65%+0.00% QoQ
FII holding
20.89%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 7Product Launch 6Financial Results 4Other Announcement 3Business Update 3Results Update 2Regulatory Approval 2Legal & Regulatory 2Board Meeting Date 2Annual General Meeting 2Merger & Restructuring 1Management Change 1Employee Stock Options 1Dividend 1Debt & Borrowing 1Credit Rating 1

Time

All time Last 1 weekLast 1 monthLast 2 monthsLast 3 monthsLast 6 monthsLast 1 year

2 announcements with these filters

19:12 IST BSE
Results Update

Glenmark Pharmaceuticals Results Update

Glenmark Pharmaceuticals reported Q1 FY27 consolidated revenue of ₹4,018.5 Crore, a 23.1% YoY growth, with an EBITDA of ₹804.8 Crore.

Value
₹4,018 Cr
Read the filing ↗
21:59 IST NSE
Results Update

Glenmark Pharmaceuticals Results Update

Glenmark Pharmaceuticals reported FY26 consolidated revenue of ₹16,982.5 Crore, up 27.5% YoY. The company achieved a 26.9% EBITDA margin driven by key product launches and partnerships.

Value
₹16,982 Cr
Read the filing ↗